NORDIC BIOTECH GENERAL PARTNER ApS: Financial statements 2015
CVR: 26270367
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
NORDIC BIOTECH GENERAL PARTNER ApS (CVR 26270367) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 17,500 and a net result of DKK 12,596 compared with DKK 15,478 the year before. That is a decrease of 17.6% compared with the year before. Equity in the 2015 report amounted to DKK 269,930. The solvency ratio was 93.1%.
- Gross Profit
- DKK 17,500
- Profit/Loss
- DKK 12,596
- Equity
- DKK 269,930
- Total Assets
- DKK 289,930
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 18K | 13K | 270K | - |
| 2014 | - | 21K | 15K | 257K | - |
| 2013 | - | 22K | 16K | 242K | - |
| 2012 | - | 21K | 15K | 226K | - |
Official annual report
How creditworthy is NORDIC BIOTECH GENERAL PARTNER ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
NORDIC BIOTECH GENERAL PARTNER ApS has published its annual report for 2014. Gross profit came to DKK 21,250, and the net result was DKK 15,478.
About NORDIC BIOTECH GENERAL PARTNER ApS
NORDIC BIOTECH GENERAL PARTNER ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Mosegaard Larsen. The company is owned by TECH GROWTH INVEST ApS and C. HANSEN INVEST ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 163,699 and a net result of DKK 178,169 compared with DKK 67,346 the year before. Equity in the 2025 report amounted to DKK 1,214,065.